SENORES PHARMACEUTICALS L (SENORES)

NSE: ₹1,044.40
BSE: ₹1,042.95
Stock Performance
Corporate Announcements
No recent announcements available.

Quarterly Financials

Consolidated Standalone
Particulars Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026 Jun 2026
Revenue from Operations 103.02 114.21 137.99 161.76 174.56 175.19 180.21
YOY Revenue Growth % - - - - 69.45% 53.39% 30.6%
Other Income 5.16 11.77 3.36 5.41 3.78 17.67 2.81
Total Income 108.17 125.98 141.35 167.17 178.34 192.86 183.02
Total Expenses + 87.69 105.30 114.86 126.53 133.74 145.46 143.56
Cost of Materials Consumed 23.10 20.94 29.38 46.09 36.96 27.05 31.15
Employee Benefit Expense 19.01 14.63 21.65 29.62 30.66 30.32 29.91
Other Expenses 17.63 22.68 20.81 25.55 22.88 31.16 30.82
Operating Profit 15.33 8.91 23.13 35.23 40.82 29.73 36.65
OPM % 14.9% 7.8% 16.8% 21.8% 23.4% 17% 20.3%
Profit Before Tax + 20.48 20.68 26.49 40.64 44.60 47.40 39.46
Tax Expense 4.05 2.71 5.31 10.52 11.02 10.73 9.01
Tax % 19.8% 13.1% 20% 25.9% 24.7% 22.6% 22.8%
Profit After Tax 16.43 17.97 21.18 30.12 33.58 36.67 30.45
EPS (Basic) 5.04 3.81 4.60 6.54 7.29 7.96 6.61

Yearly Financial Results

Consolidated Standalone
Particulars Mar 2026 Mar 2025
Revenue from Operations 632.63 398.25
YOY Revenue Growth % 58.85% -
Other Income 47.06 19.26
Total Income 679.69 417.51
Total Expenses + 520.59 346.94
Cost of Materials Consumed 114.27 91.64
Employee Benefit Expense 112.25 60.37
Other Expenses 100.40 67.48
Operating Profit 112.04 51.31
OPM % 17.7% 12.9%
Profit Before Exceptional 159.10 70.57
Exceptional Items 0.00 0.00
Profit Before Tax + 159.10 70.57
Tax Expense 37.57 12.23
Tax % 23.6% 17.3%
Profit After Tax 121.53 58.34
EPS (Basic) 26.39 16.12

Balance Sheet

Particulars Mar 2026 Mar 2025
ASSETS
Non-Current Assets + 791.38 504.43
Property, Plant & Equipment 331.37 198.85
Capital Work in Progress 17.46 44.17
Non-Current Investments 4.29 0.01
Goodwill 46.55 38.21
Other Intangible Assets 106.79 54.27
Current Assets + 812.43 722.43
Inventories 89.29 56.63
Trade Receivables 324.82 123.88
Cash and Cash Equivalents 45.55 105.38
Current Investments 0.00 0.00
LIABILITIES & EQUITY
Total Equity 964.54 812.24
Equity Share Capital 46.05 46.05
Other Equity 887.55 740.13
Non-Current Liabilities 215.27 173.92
Current Liabilities 424.00 240.70
Total Liabilities 639.27 414.62

Cash Flow Statement

Particulars Mar 2026 Mar 2025
Cash from Operating Activities 62.05 -45.92
Cash from Investing Activities -120.56 -429.48
Cash from Financing Activities -1.32 573.14
Net Increase/Decrease in Cash -59.83 97.74